Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes

Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Mar 15, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how diabetes in children and teenagers can lead to heart and blood vessel problems, known as atherosclerotic cardiovascular disease (ASCVD). Researchers want to understand how to predict the risk of these heart issues in young people with type 1 or type 2 diabetes. They believe that ASCVD can start early in life for those with diabetes, so it’s important to find ways to identify and manage this risk as soon as possible.

To participate in this study, individuals must be diagnosed with type 1 or type 2 diabetes before they turned 18 and have been living with diabetes for at least 5 years. The study is open to both males and females who are now 18 years or older. Participants will be monitored to help researchers learn more about the connection between childhood diabetes and heart disease. It’s worth noting that certain health conditions or recent treatments may prevent someone from joining the study. This research is crucial as it aims to improve the health and future of young people living with diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosis of type 1 diabetes or type 2 diabetes
• • 2. Age of onset: \<18y
• • 3. Enrollment age: ≥18y
• • 4. Gender: male or female
• • 5. Diabetes duration ≥ 5 years
• Exclusion Criteria:
• • 1. Specific types of diabetes
• • 2. Clinical diagnosis of diabetes is unknown, and it belongs to untyped diabetes
• • 3. Pregnancy or lactation
• • 4. Received glucocorticoids, immunosuppressants, non-glycemic biological agents, and cytotoxic drugs in the past 3 months; non-steroidal pain relievers or antibiotics used for more than 1 week continuously
• • 5. Onset of acute complications of diabetes in the past 3 months
• • 6. Major trauma and surgery history in the past 3 months